Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,494.00
Bid: 7,480.00
Ask: 7,483.00
Change: 76.00 (1.02%)
Spread: 3.00 (0.04%)
Open: 7,450.00
High: 7,507.00
Low: 7,422.00
Yest. Close: 7,418.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

AstraZeneca says reports COVID-19 vaccine efficacy is low in elderly are incorrect

Mon, 25th Jan 2021 21:26

FRANKFURT, Jan 25 (Reuters) - AstraZeneca on Monday
described German media reports saying its COVID-19 vaccine was
shown to have a very low efficacy in the elderly as "completely
incorrect".

German daily papers Handelsblatt and Bild said in separate
reports on Monday the vaccine - co-developed by AstraZeneca and
Oxford University - had an efficacy of 8% or less than 10%,
respectively, in those over 65 and the German government did not
expect the European regulator to approve the product for that
age group.
(Reporting by Ludwig Burger)

More News

UPDATE 1-J&J to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says

(Adds details of collaboration, scientific paper)By John MillerZURICH, April 20 (Reuters) - A German scientist studying extremely rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday Johnson & Johnson has agreed to work with h...

Today 20:35

UPDATE 2-J&J to cooperate in study of rare clots linked to COVID-19 vaccine, German scientist says

(Adds details on class of vaccines)By John MillerZURICH, April 20 (Reuters) - A German scientist studying extremely rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday Johnson & Johnson has agreed to work with him on the rese...

Today 20:35

German scientist: J&J to cooperate in study of rare clots linked to COVID-19 vaccine

ZURICH, April 20 (Reuters) - A German scientist studying rare blood clots linked to AstraZeneca's COVID-19 vaccine said on Tuesday that Johnson & Johnson had agreed to collaborate with him on research into similar events associated with its own C...

Today 17:54

European Medicines Agency: More than 300 cases of rare blood clot events worldwide

AMSTERDAM, April 20 (Reuters) - The European Union's drug regulator said on Tuesday there had been more than 300 cases worldwide of rare blood clotting incidents combined with low platelet counts after use of COVID-19 vaccines.There were 287 occur...

Today 16:22

UPDATE 1-Mexico president receives AstraZeneca vaccine against COVID-19

(Adds context on AstraZeneca, quotes)MEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca shot against COVID-19 on Tuesday, urging trust in vaccines after several countries limited the use of Ast...

Today 15:54

UPDATE 2-Mexico president touts 'no risks' as he receives AstraZeneca vaccine

(Adds details on Mexico vaccine supply)By Daina Beth SolomonMEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca shot against COVID-19 on Tuesday, urging trust in vaccines after several countries...

Today 15:54

UPDATE 1-EU regulator finds possible link between J&J COVID-19 vaccine and blood clots

(Adds details from EMA statement)April 20 (Reuters) - Europe's drug regulator said on Tuesday it had found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who had received the shot in the Unite...

Today 15:26

UPDATE 2-EU regulator backs J&J vaccine despite finding possible link to blood clots

* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Writes through with details, background)April 20 (Reuters) - Europe's drug regulator has f...

Today 15:26

UPDATE 3-EU regulator backs J&J shot, finds possible link to clots

* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adds details, quotes from EMA news conference)By Pushkala Aripaka and Anthony DeutschApril...

Today 15:26

UPDATE 4-EU regulator backs J&J shot, finds possible link to clots

* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adding details throughout)By Pushkala Aripaka, Anthony Deutsch and John MillerApril 20 (Re...

Today 15:26

UPDATE 5-EU regulator backs J&J shot, finds possible link to clots

* EMA assessed 8 cases of serious clots in the United States* Says overall benefits outweigh any risks* Cases occurred in adults under 60, most of them women (Adds details throughout)By Pushkala Aripaka, Anthony Deutsch and John MillerApril 20 (Reut...

Today 15:26

Mexico president receives AstraZeneca vaccine against COVID-19

MEXICO CITY, April 20 (Reuters) - Mexican President Andres Manuel Lopez Obrador received the AstraZeneca vaccine against COVID-19 at his regular daily news conference on Tuesday.The 67-year-old, who had contracted the coronavirus in January, said ...

Today 15:15

EU regulator finds possible link between J&J COVID-19 vaccine and blood clots

April 20 (Reuters) - Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who had received the shot in the United States, the watchdog said on Tuesday.(Reporting b...

Today 15:12

UPDATE 1-Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

(Adds details, background)By John MillerZURICH, April 20 (Reuters) - Switzerland's drug regulator is still awaiting data needed to consider AstraZeneca's COVID-19 vaccine candidate for approval, a Swissmedic official said on Tuesday, adding the in...

Today 14:23

UPDATE 2-Switzerland 'unfortunately' still awaiting AstraZeneca COVID-19 vaccine data - official

* Alpine nation has approved 3 COVID-19 vaccines, so far* Swiss expect 8 mln Q2 vaccine doses, despite Moderna hiccups (Adds detail in 6th paragraph about possible recommendation for AstraZeneca vaccine, following rare blood clots)By John MillerZU...

Today 14:23

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.